Delinieation of GIP's Effects During a Meal in Humans Using GIP Receptor Antagonisation (GA-4)

NCT03013296 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Glucose Metabolism Disorders

Interventions

OTHER: GIP-A
OTHER: Placebo
OTHER: GLP-1 receptor antagonist Exendin[9-39]
OTHER: GIP-A + Exendin[9-39]

Sponsor

University Hospital, Gentofte, Copenhagen

Collaborators

[object Object]